A.15 bone mineral homeostasis Flashcards

1
Q

what are the primary hormonal modulators of bone mineral homeostasis?

A
parathyroid hormone (PTH)
Vitamin D
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the secondary hormonal modulators of bone mineral homeostasis?

A

calcitonin, estrogens, glucocorticoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the non-hormonal modulators of bone mineral homeostasis?

A

Bisphosphonates
RANK-ligand inhibitors
Calcimimetics
Fluoride

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is Teriparatide and how is it given?

A

PTH analogue, SC injection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the indication for teriparatide?

A

osteoporosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

SE of teriparatide?

A

hypercalcemia, hypercalcuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

function of PTH

A
  1. kidney: Ca² excretion↓ P excretion ↑, synthesis of vit D
  2. bone: osteoclast and osteoblast stimulation
  3. intestine: Ca² and P absorption ↑ (indirect effect mediated by vit D)

net effect: Ca² ↑ P ↓

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

function of Vitamin D

A
  1. kidney: Ca² and P reabsorption↑
  2. bone: direct effect–> bone resorption ↑serum Ca² and P
  3. intestine: Ca² and P absorption↑
  4. inhibit PTH release

net effect: Ca² ↑ P ↑

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what do vitamin d2 and d3 require that calcitriol (active form) doesn’t?

A

metabolism in liver or kidney to become active

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

analogue of calcitriol

A

doxercalciferol
paricalcitol
calcipotriene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

which vitamin D drug is given topically?

A

calcipotriene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

indications for Ergocalciferol (Vit D2) and Cholecalciferol (Vit D3) ?

A

vitamin D deficiency- rickets disease, osteomalacia, nutritional deficiency, hypoparathyroidism, nephrotic syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

SE of Ergocalciferol (Vit D2) and Cholecalciferol (Vit D3)

A

hypercalcemia, hyperphosphatemia, hypercalcuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

indications for calcitriol

A

secondary hyperparathyroidism in patients with chronic kidney disease
hypocalcemia in patients with hypoparathyroidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

indications for Doxercalciferol and paricalcitol?

A

secondary hyperparathyroidism in patients with chronic kidney disease
(milder SE than calcitriol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

indication for calcipotriene

A

psoriasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

function of calcitonin

A
  1. Kidney: Ca² and P excretion↑
  2. inhibits osteoclast activity–>↓ bone resorption

net effect: Ca²↓
CALCITONIN –>tones down the Ca² level, keeps it in the bones.

18
Q

how is calcitonin given?

A

SC, nasal spray

19
Q

indications for calcitonin

A

osteoporosis
paget’s disease
hypercalcemia- acute management

20
Q

SE of calcitonin

A

rhinitis with the nasal spray, hypocalcemia

21
Q

What is Raloxifene and what is it’s function

A

SERM- selective estrogen receptor modulator

inhibits PTH-induced bone resorption by inhibiting osteoclast activity

22
Q

indication for raloxifene

A

post-menopausal osteoprosis

23
Q

SE of Raloxifene

A

hot flushes, ↑ risk of venous thromboembolism

24
Q

glucocorticoids function

A
  1. intestinal and renal Ca² absorption↓
  2. RANK-L stimulation
  3. inhibit osteoblast and collagen synthesis
25
Q

what risk is there in prolonged use of GC?

A

osteoporosis (in systemic therapy)

26
Q

name 2 bisphosphonates

A

Alendronate
Zoledronate
Risedronate

27
Q

what is the function of bisphosphonates?

A
  1. direct suppression of osteoclast activity

2. increase of bone mineral density in the first year of use

28
Q

how is alendronate given?

A

oral or parenteral

29
Q

indications for alendronate, zoledronate?

A

osteoporosis (1st line treatment)
Paget’s disease
bone metastasis
hypercalcemia due to hyperparathyroidism

30
Q

SE for bisphosphonates?

A

hypocalcemia, upper GI irritation, osteonecrosis of the jaw (rare, with IV use)

31
Q

what is Denosumab and how is it given?

A

RANK-ligand inhibitor
human monoclonal antibody (IgG)
SC injection every 6 months

32
Q

what is the function of denosumab?

A

inhibit RANK-L stimulation of osteoclast activity–> ↓ bone resorption

33
Q

indication of denosumab?

A

Post-menopausal osteoporosis

34
Q

SE of denosumab

A

increased risk of infection

35
Q

what is Cinacalcet and how is it given?

A

it’s a calcimimetic (mimics the action of Ca² on tissues)
activates Ca² sensing receptor–> ↓PTH–> ↓ Ca²
given orally

36
Q

indications for Cinacalcet

A

secondary hyperparathyroidism due to chronic kidney disease

parathyroid carcinoma management

37
Q

SE of Cinacalcet

A

nausea, hypocalcemia

38
Q

risk factors for developing primary osteoporosis

A

endocrine: hypothyroidism, Type 1 DM
GI: malabsorption, vitamin D and C deficiency
Drug-induced: anticoagulants, chemotherapy , alcohol

39
Q

what is osteoporosis?

A

reduction of the bone strength that leads to an increased risk of fractures (vertebal and hip mostly)

40
Q

how do we measure bone mineral density?

A

DEXA scan - dual energy X-ray absorptiometry

graded based on the T score

41
Q

classification of BMD (based on T score)

A

normal: -1.0 or greater
osteopenia: between -1.0 and -2.5
osteoporosis: -2.5 or less
severe osteoporosis: -2.5 or less with a pathologic fracture

42
Q

pharmacological management of osteoporosis

A
  1. SERM- Raloxifene
  2. Bisphosphonate
  3. RANK-L inhibitors (denosumab)
  4. calcitonin analogues
  5. PTH analogues
  6. Ca² supplementation
  7. Vitamin D supplementation
  8. thiazide diuretics